SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

VolitionRx Signs Non-Binding LOI to Develop NETosis Test

VolitionRx signed a non-binding LOI with Missionpharma to explore development, manufacturing support and distribution of a prototype lateral flow test for NETosis, including potential decentralized use in LMICs and neonatal sepsis triage.

VNRX

Related stories